---
figid: PMC4951304__oncotarget-07-18495-g001
figlink: /pmc/articles/PMC4951304/figure/F1/
number: F1
caption: The checkpoint response is dependent on three effector axes coordinated through
  the transcription factor FoxO3a. In arrested cells, FoxO3a activates the ARF-|Hdm2-|p53→p21
  pathway and mediates p15(INK4B) upregulation. p53 in turn activates expression of
  the Wnt/β-catenin signalling antagonist Dkk3, leading to Myc and cyclin D1 downregulation.
  The resulting loss of CDK activity inactivates the Rb-E2F pathway resulting in G1
  arrest. The lack of redundancy between the checkpoint axes and reliance on several
  tumour suppressor proteins commonly inactivated in human tumours provides a mechanistic
  basis for the cancer-cell-specific killing observed following targeting of Cdc7.
  Notably multiple core components of this checkpoint pathway are mutated in pancreatic
  cancer (circled in red) thus sensitizing this tumour type to Cdc7 directed agents
  (adapted from Tudzarova et al, EMBO J. 2010 Oct 6;29(19):3381-94, Figure ).
pmcid: PMC4951304
papertitle: Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation
  of the DNA origin activation checkpoint.
reftext: Matthew T. Huggett, et al. Oncotarget. 2016 Apr 5;7(14):18495-18507.
pmc_ranked_result_index: '7239'
pathway_score: 0.9232709
filename: oncotarget-07-18495-g001.jpg
figtitle: Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation
  of the DNA origin activation checkpoint
year: '2016'
organisms:
- Homo sapiens
ndex: b652e347-deba-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4951304__oncotarget-07-18495-g001.html
  '@type': Dataset
  description: The checkpoint response is dependent on three effector axes coordinated
    through the transcription factor FoxO3a. In arrested cells, FoxO3a activates the
    ARF-|Hdm2-|p53→p21 pathway and mediates p15(INK4B) upregulation. p53 in turn activates
    expression of the Wnt/β-catenin signalling antagonist Dkk3, leading to Myc and
    cyclin D1 downregulation. The resulting loss of CDK activity inactivates the Rb-E2F
    pathway resulting in G1 arrest. The lack of redundancy between the checkpoint
    axes and reliance on several tumour suppressor proteins commonly inactivated in
    human tumours provides a mechanistic basis for the cancer-cell-specific killing
    observed following targeting of Cdc7. Notably multiple core components of this
    checkpoint pathway are mutated in pancreatic cancer (circled in red) thus sensitizing
    this tumour type to Cdc7 directed agents (adapted from Tudzarova et al, EMBO J.
    2010 Oct 6;29(19):3381-94, Figure ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - E2F7
  - E2F2
  - E2F1
  - CDC7
  - CDKN2B
  - E2F3
  - CDKN2A
  - E2F5
  - CDKN1B
  - TP53
  - E2F4
  - CDK6
  - CCND1
  - DKK3
  - MYC
  - CDK4
  - MDM2
  - E2F6
  - CDK2
  - E2F8
  - Cancer
genes:
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: Cdc7
  symbol: CDC7
  source: hgnc_symbol
  hgnc_symbol: CDC7
  entrez: '8317'
- word: P15INK4B
  symbol: p15INK4b
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2B
  entrez: '1030'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: P14ARF
  symbol: p14ARF
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: P27KIP1
  symbol: P27KIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1B
  entrez: '1027'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: cyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Dkk3
  symbol: DKK3
  source: hgnc_symbol
  hgnc_symbol: DKK3
  entrez: '27122'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Hdm2
  symbol: HDM2
  source: hgnc_alias_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4951304__F1
redirect_from: /figures/PMC4951304__F1
figtype: Figure
---
